During the past decade, Center for Lymphoid Malignancies at CUMC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Lymphoid Malignancies at CUMC" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Center for Lymphoid Malignancies at CUMC" are "Anaplastic Large Cell Lymphoma" (1 trials), "Hodgkin Lymphoma" (1 trials), "Hodgkin's Disease" (1 trials), "Lymphoma, T-Cell, Cutaneous" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Center for Lymphoid Malignancies at CUMC" in a lesser frequency.

Most popular intervention types in "Center for Lymphoid Malignancies at CUMC" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "AFM13" (2 trials), "Bendamustine" (1 trials), "Brentuximab Vedotin" (1 trials), "Etoposide" (1 trials) and "Neulasta" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Lymphoid Malignancies at CUMC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Center for Lymphoid Malignancies at CUMC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Center for Lymphoid Malignancies at CUMC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Lymphoid Malignancies at CUMC, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".